Are you a medical professional interested in autoimmune encephalitis?
Treat AIE on Friday and Saturday is networking conference from @EANeurology & @EJPRareDiseases aimed at providing guidelines and improving the treatment of AE.
Book a free place 👇
https://t.co/61v3VSKHDc
📢 NEW VACANCY | In2research Alumni Coordinator
Involves building the Alumni support package for In2research (@in2scienceUK), a social mobility programme, continuing support for our graduates into their academic careers.
📅 9 May | Ref 1883037
https://t.co/y6iL2jLglz
Thank you to all the ESGIB members who made neurological infections `#ECCMID2022 so much fun. Great data, great colleagues, fabulous speakers and so much interaction. Wonderful to be back in person again
ISID/ESCMID fellowship applications are still open! Two fellowships are awarded annually to residents of #LMICs who can benefit from the opportunity to work or study outside of their country in Europe!
Deadline to apply 31 May 2022
Learn more: https://t.co/NUMWQNFp8q
@ISID_org
Only 2 weeks left to register for Europneumo 2022 https://t.co/xaq0PbT82T. We can now reveal the conference is to be held at the Museum of Liverpool, located on the waterfront. Looking forward to welcoming you soon!#Europneumo2022@BacPathLiv
Certain ESCMID Study Groups are currently having elections for their Executive Committees. The voting phase is open and members are encouraged to vote for their favorite candidates before March 17th.
Login and vote here: https://t.co/hEHadUTSsH
ESCMID is looking for Twitter Ambassadors for #ECCMID2022. If you want to apply to be a part of our Twitter Team, fill out the survey with the link below. Twitter ambassadors will get onsite access to the #VIP Lounge.
Deadline to apply: March 15
https://t.co/rrOlOamgdY
Register now for this annual course, a highlight of the British Neurology calendar! Neurology 2022: leading edge neurology for the practising clinician 24th and 25th March 2022 https://t.co/jL0jId94TI
ISID/ESCMID fellowship applications are now open! Two fellowships are awarded annually to residents of #LMICs who can benefit from the opportunity to work or study outside of their country in Europe!
Deadline to apply 31 May 2022
Learn more: https://t.co/NUMWQNFp8q
@ISID_org
🗓️ Mark your calendars for #ESCV2022!
It is our pleasure to invite you to the 24th ESCV Annual Meeting to be held in #Manchester, UK on 7th-10th September 2022.
Learn more 👉 https://www.escv2022
#ClinicalVirology#ViralDiseases
HOT OFF THE PRESS- Consensus Guidance on Management of #COVID Brain Dysfunction #encephalitis#encephalopathy. Huge thanks to https://t.co/yA34bEKyEe for getting out- #WorldEncephalitisDay
INSPIRING COLLABORATION
Across Neuroscience & Globe
FULL TEXT:
https://t.co/tok4emm1Jr
This year #ECCMID2022 is hybrid for the first time, and our online platform is already available to access for registrants. Be sure to check it out and get familiar before the first #PreECCMID day this Wednesday, 23 February.
Access it here: https://t.co/bIBvn69qtA
Calling all pneumococcal scientists - the fabulous Europneumo is back and its a live in-person conference in liverpool. Not too late to submit an abstract and sign up for the meeting
👇
The 15th European Meeting on the Molecular Biology of the Pneumococcus (Europneumo) coming to Liverpool soon! 31 May-3 June 2022 https://t.co/uWn6n7IeaB latest research in pathogenesis, genomics, immunology, vaccines, and plenty more. We look forward to seeing you in Liverpool!
New innovative approaches are required to address pneumococcal disease caused by residual non-vaccine serotypes and replacement serotypes. Delighted to have discussed potential approaches with this incredible panel of pneumo-experts @M_R_F conference, @NIHR_MPRU@UCLInfectImm
We’re recruiting a🧑🎓 PhD student @TheCrick to join our group in 2022! Project on role of 🧬 RNA structure in 🦠😷 virus infections, and using this info to improve 💊💉treatment for disease. Fully funded, pls RT! https://t.co/RyFxpGcajN ... 1/3
Have you booked your place at the 2021 Encephalitis Conference? Brought to you by @encephalitis, the event will be held both virtually and in-person on 7th December. https://t.co/99f2VxRKSC
#ISSAD2021 begins with @DrTedros launching the value proposition for a GBS vaccine.
Group B Strep is the leading cause of bacterial meningitis and sepsis in neonates. No vaccine is currently available to prevent this deadly disease.
To #DefeatMeningitis, we must defeat GBS.